CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 59 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04458675
NCT04458675Phase 4Completed

A Prospective, Multicenter, Randomized, Single Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Vibrant Capsule vs. Vibrant Placebo for the Treatment of Chronic Idiopathic Constipation (CIC)

Vibrant Ltd.·interventional·Posted Jul 7, 2020·Updated Jun 14, 2024

In Brief

A Phase 4 clinical trial evaluating Vibrant capsule and Placebo for Chronic Idiopathic Constipation. Completed, enrolled 59 participants across 1 site.

Detailed Summary

The was performed to assess the safety and efficacy of the vibrant capsule vs. placebo for the treatment of subjects with functional Constipation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20192020202120222023202420252026
First PostedJul 7, 2020
Enrollment StartJul 26, 2018
Primary CompletionJan 7, 2019
Study CompletionMar 30, 2019
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 6.0 years ago

Interventions

Vibrant capsuledevice

The capsule vibration mechanically stimulates the inner wall of the GI and stimulates motility

Placebodrug

A biodegradable capsule, which visually similar to the Vibrant active capsule